Redentes dantų protezų laboratorija - Company finances
|
EUR
|
2020
From: 2020-08-13
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 1,880 | 7,500 | 3,344 | 2,690 | 6,785 | 11,387 |
| Profit before tax | 600 | 1,309 | -913 | -825 | 3,100 | 49 |
| Net profit | 570 | 1,244 | -913 | -825 | 2,945 | 46 |
| Equity | 770 | 2,014 | 1,101 | 276 | 3,221 | 3,267 |
| Liabilities | - | - | 259 | 415 | 769 | 67 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 1,886 | 2,513 | 1,360 | 691 | 3,990 | 3,334 |
| Total assets | 1,886 | 2,513 | 1,360 | 691 | 3,990 | 3,334 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | - | 2 | 157 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +298.9% | -55.4% | -19.6% | +152.2% | +67.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 30.2% | 49.5% | -67.1% | -119.4% | 73.8% | 1.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 74.0% | 61.8% | -82.9% | -298.9% | 91.4% | 1.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 30.3% | 16.6% | -27.3% | -30.7% | 43.4% | 0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 31.9% | 17.5% | -27.3% | -30.7% | 45.7% | 0.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.2 | 1.5 | 0.2 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Redentes dantų protezų laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-03 | 2024-05-31 | 101.20 |
| 2024-05-02 | 2024-05-02 | 29.67 |
| 2024-03-29 | 2024-04-30 | 0.01 |
Redentes dantų protezų laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-20 | 2026-06-05 | 7.0 |
| 2026-02-21 | 2026-03-08 | 7.0 |
| 2025-06-19 | 2026-02-20 | 4.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Redentes, MB (company code 305602711) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €11.4K, up 67.8% year on year and 323.3% above the 2023 level. Despite the stronger turnover, profitability remained very limited: net profit was €46, compared with €2.9K in 2024 and a loss of €825 in 2023. The 2025 profit margin was 0.4%, showing that revenue growth did not translate into meaningful earnings. The balance sheet remained very conservative, with total assets of €3.3K, equity of €3.3K and liabilities of €67. Equity accounted for 98.0% of assets, while debt to equity stood at 0.02. Return on equity and return on assets were both 1.4% in 2025, and asset turnover was 3.42x. Overall, the company moved from a loss in 2023 to a strong profit year in 2024, before returning to near break-even profitability in 2025.